Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan

BACKGROUND: A large body of evidence suggests that long-acting β2-adrenoceptor agonist (LABA)/long-acting muscarinic antagonist (LAMA) combinations induce a strong synergistic bronchodilatory effect in human isolated airways. Moreover, a recent post hoc analysis demonstrated clinical synergism betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hideyasu, Hida, Norihito, Hizawa, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183692/
https://www.ncbi.nlm.nih.gov/pubmed/30349222
http://dx.doi.org/10.2147/COPD.S179285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183692/
https://www.ncbi.nlm.nih.gov/pubmed/30349222
http://dx.doi.org/10.2147/COPD.S179285

Ejemplares similares